PainReform Ltd. Announces Public Offering of Shares and Warrants
Ticker: PRFX · Form: 6-K · Filed: Apr 17, 2024 · CIK: 1801834
| Field | Detail |
|---|---|
| Company | Painreform Ltd. (PRFX) |
| Form Type | 6-K |
| Filed Date | Apr 17, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.80, $0.7999, $0.0001, $50,000, $100,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: offering, securities, capital-raise
TL;DR
PainReform is selling shares and warrants in a public offering.
AI Summary
On April 15, 2024, PainReform Ltd. entered into a definitive securities purchase agreement for a public offering. The offering involves the sale of 447,500 ordinary shares and 4,552,500 pre-funded warrants. The company is a pharmaceutical preparations company based in Tel Aviv, Israel.
Why It Matters
This filing indicates PainReform Ltd. is raising capital through a public offering, which could fund further development or operations.
Risk Assessment
Risk Level: medium — Public offerings can dilute existing shareholders and signal a need for capital, but also provide funds for growth.
Key Numbers
- 447,500 — Ordinary Shares (Offered in public sale)
- 4,552,500 — Pre-funded Warrants (Offered in public sale)
Key Players & Entities
- PainReform Ltd. (company) — Registrant
- April 15, 2024 (date) — Date of purchase agreement
- 447,500 (dollar_amount) — Number of ordinary shares in the offering
- 4,552,500 (dollar_amount) — Number of pre-funded warrants in the offering
FAQ
What is the purpose of the public offering announced by PainReform Ltd. on April 15, 2024?
The filing states the company entered into a definitive securities purchase agreement for a public offering of ordinary shares and pre-funded warrants, but does not specify the exact use of proceeds.
How many ordinary shares is PainReform Ltd. offering?
PainReform Ltd. is offering 447,500 of its ordinary shares.
How many pre-funded warrants are included in the offering?
The offering includes 4,552,500 pre-funded warrants.
What is the par value of PainReform Ltd.'s ordinary shares?
The par value of PainReform Ltd.'s ordinary shares is NIS 0.30 per share.
When did PainReform Ltd. enter into the securities purchase agreement?
PainReform Ltd. entered into the definitive securities purchase agreement on April 15, 2024.
Filing Stats: 1,282 words · 5 min read · ~4 pages · Grade level 12.3 · Accepted 2024-04-17 16:16:38
Key Financial Figures
- $0.80 — stor Warrants"), at a purchase price of $0.80 per Share and accompanying Investor War
- $0.7999 — e and accompanying Investor Warrant and $0.7999 per Pre-Funded Warrant and accompanying
- $0.0001 — ely exercisable at an exercise price of $0.0001 per Ordinary Share and will not expire
- $50,000 — n-accountable expenses in the amount of $50,000, legal fees and expenses and other out-
- $100,000 — t-of-pocket expenses in an amount up to $100,000 and clearing expenses in the amount of
- $15,950 — learing expenses in the amount of up to $15,950. Under the terms of the Engagement Agre
- $1.00 — gent Warrants have an exercise price of $1.00 per Ordinary Share, are exercisable beg
- $4.0 million — any from the Offering are approximately $4.0 million before deducting estimated offering exp
Filing Documents
- zk2431308.htm (6-K) — 23KB
- exhibit_10-5.htm (EX-10.5) — 10KB
- 0001178913-24-001359.txt ( ) — 34KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PainReform Ltd. Date: April 17, 2024 By: /s/ Ilan Hadar Ilan Hadar Chief Executive Officer